Kevin Robert Lind - 09 Feb 2023 Form 4 Insider Report for Longboard Pharmaceuticals, Inc. (LBPH)

Role
CEO, Director
Signature
/s/ Brandi L. Roberts, Attorney-In-Fact
Issuer symbol
LBPH
Transactions as of
09 Feb 2023
Net transactions value
$0
Form type
4
Filing time
10 Feb 2023, 15:27:01 UTC
Previous filing
11 Feb 2022
Next filing
09 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Award $0 +325,850 $0.000000 325,850 09 Feb 2023 Voting common stock 325,850 $4.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2023.